Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)

DOI record: { "DOI": "10.1016/j.eclinm.2024.103036", "ISSN": [ "2589-5370" ], "URL": "http://dx.doi.org/10.1016/j.eclinm.2024.103036", "alternative-id": [ "S2589537024006151" ], "article-number": "103036", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)" }, { "label": "Journal Title", "name": "journaltitle", "value": "eClinicalMedicine" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.eclinm.2024.103036" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2025 The Authors. Published by Elsevier Ltd." } ], "author": [ { "affiliation": [], "family": "Jittamala", "given": "Podjanee", "sequence": "first" }, { "affiliation": [], "family": "Boyd", "given": "Simon", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-6328-8748", "affiliation": [], "authenticated-orcid": false, "family": "Schilling", "given": "William H.K.", "sequence": "additional" }, { "affiliation": [], "family": "Watson", "given": "James A.", "sequence": "additional" }, { "affiliation": [], "family": "Ngamprasertchai", "given": "Thundon", "sequence": "additional" }, { "affiliation": [], "family": "Siripoon", "given": "Tanaya", "sequence": "additional" }, { "affiliation": [], "family": "Luvira", "given": "Viravarn", "sequence": "additional" }, { "affiliation": [], "family": "Batty", "given": "Elizabeth M.", "sequence": "additional" }, { "affiliation": [], "family": "Wongnak", "given": "Phrutsamon", "sequence": "additional" }, { "affiliation": [], "family": "Esper", "given": "Lisia M.", "sequence": "additional" }, { "affiliation": [], "family": "Almeida", "given": "Pedro J.", "sequence": "additional" }, { "affiliation": [], "family": "Cruz", "given": "Cintia", "sequence": "additional" }, { "affiliation": [], "family": "Ascencao", "given": "Fernando R.", "sequence": "additional" }, { "affiliation": [], "family": "Aguiar", "given": "Renato S.", "sequence": "additional" }, { "affiliation": [], "family": "Ghanchi", "given": "Najia K.", "sequence": "additional" }, { "affiliation": [], "family": "Callery", "given": "James J.", "sequence": "additional" }, { "affiliation": [], "family": "Singh", "given": "Shivani", "sequence": "additional" }, { "affiliation": [], "family": "Kruabkontho", "given": "Varaporn", "sequence": "additional" }, { "affiliation": [], "family": "Ngernseng", "given": "Thatsanun", "sequence": "additional" }, { "affiliation": [], "family": "Tubprasert", "given": "Jaruwan", "sequence": "additional" }, { "affiliation": [], "family": "Madmanee", "given": "Wanassanan", "sequence": "additional" }, { "affiliation": [], "family": "Suwannasin", "given": "Kanokon", "sequence": "additional" }, { "affiliation": [], "family": "Promsongsil", "given": "Amornrat", "sequence": "additional" }, { "affiliation": [], "family": "Hanboonkunupakarn", "given": "Borimas", "sequence": "additional" }, { "affiliation": [], "family": "Poovorawan", "given": "Kittiyod", "sequence": "additional" }, { "affiliation": [], "family": "Potaporn", "given": "Manus", "sequence": "additional" }, { "affiliation": [], "family": "Srisubat", "given": "Attasit", "sequence": "additional" }, { "affiliation": [], "family": "Loharjun", "given": "Bootsakorn", "sequence": "additional" }, { "affiliation": [], "family": "Taylor", "given": "Walter R.J.", "sequence": "additional" }, { "affiliation": [], "family": "Qamar", "given": "Farah", "sequence": "additional" }, { "affiliation": [], "family": "Kazi", "given": "Abdul Momin", "sequence": "additional" }, { "affiliation": [], "family": "Beg", "given": "M. Asim", "sequence": "additional" }, { "affiliation": [], "family": "Chommanam", "given": "Danoy", "sequence": "additional" }, { "affiliation": [], "family": "Vidhamaly", "given": "Sisouphanh", "sequence": "additional" }, { "affiliation": [], "family": "Chotivanich", "given": "Kesinee", "sequence": "additional" }, { "affiliation": [], "family": "Imwong", "given": "Mallika", "sequence": "additional" }, { "affiliation": [], "family": "Pukrittayakamee", "given": "Sasithon", "sequence": "additional" }, { "affiliation": [], "family": "Dondorp", "given": "Arjen M.", "sequence": "additional" }, { "affiliation": [], "family": "Day", "given": "Nicholas P.J.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-6944-3008", "affiliation": [], "authenticated-orcid": false, "family": "Teixeira", "given": "Mauro M.", "sequence": "additional" }, { "affiliation": [], "family": "Piyaphanee", "given": "Watcharapong", "sequence": "additional" }, { "affiliation": [], "family": "Phumratanaprapin", "given": "Weerapong", "sequence": "additional" }, { "affiliation": [], "family": "White", "given": "Nicholas J.", "sequence": "additional" } ], "container-title": "eClinicalMedicine", "container-title-short": "eClinicalMedicine", "content-domain": { "crossmark-restriction": true, "domain": [ "thelancet.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 1, 18 ] ], "date-time": "2025-01-18T18:54:25Z", "timestamp": 1737226465000 }, "deposited": { "date-parts": [ [ 2025, 2, 4 ] ], "date-time": "2025-02-04T17:54:24Z", "timestamp": 1738691664000 }, "funder": [ { "DOI": "10.13039/100010269", "award": [ "223195/Z/21/Z" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100010269", "id-type": "DOI" } ], "name": "Wellcome Trust" } ], "indexed": { "date-parts": [ [ 2025, 2, 4 ] ], "date-time": "2025-02-04T18:10:23Z", "timestamp": 1738692623662, "version": "3.37.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 2 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T00:00:00Z", "timestamp": 1738368000000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 12, 16 ] ], "date-time": "2024-12-16T00:00:00Z", "timestamp": 1734307200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2589537024006151?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2589537024006151?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "103036", "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 2 ] ] }, "published-print": { "date-parts": [ [ 2025, 2 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1056/NEJMoa2021436", "article-title": "Dexamethasone in hospitalized patients with Covid-19", "doi-asserted-by": "crossref", "first-page": "693", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2024.103036_bib1", "volume": "384", "year": "2021" }, { "DOI": "10.1016/S0140-6736(22)00372-5", "article-title": "The global COVID-19 treatment divide", "author": "Usher", "doi-asserted-by": "crossref", "first-page": "779", "journal-title": "Lancet", "key": "10.1016/j.eclinm.2024.103036_bib2", "volume": "10327", "year": "2022" }, { "DOI": "10.1111/bcp.15783", "article-title": "Post-marketing safety concerns with nirmatrelvir: a disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System", "author": "Zhuang", "doi-asserted-by": "crossref", "first-page": "2830", "journal-title": "Br J Clin Pharmacol", "key": "10.1016/j.eclinm.2024.103036_bib3", "volume": "9", "year": "2023" }, { "DOI": "10.1016/S1473-3099(23)00493-0", "article-title": "Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial", "author": "Schilling", "doi-asserted-by": "crossref", "first-page": "36", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib4", "volume": "24", "year": "2023" }, { "DOI": "10.1038/s41586-023-06649-6", "article-title": "A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes", "author": "Sanderson", "doi-asserted-by": "crossref", "first-page": "594", "journal-title": "Nature", "key": "10.1016/j.eclinm.2024.103036_bib5", "volume": "623", "year": "2023" }, { "DOI": "10.1038/s41380-021-01021-4", "article-title": "Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study", "author": "Hoertel", "doi-asserted-by": "crossref", "first-page": "5199", "journal-title": "Mol Psychiatry", "key": "10.1016/j.eclinm.2024.103036_bib6", "volume": "26", "year": "2021" }, { "DOI": "10.1001/jamanetworkopen.2021.33090", "article-title": "Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants", "author": "Oskotsky", "doi-asserted-by": "crossref", "journal-title": "JAMA Netw Open", "key": "10.1016/j.eclinm.2024.103036_bib7", "volume": "4", "year": "2021" }, { "article-title": "Antidepressant use and its association with 28-day mortality in inpatients with SARS-CoV-2: support for the FIASMA model against COVID-19", "author": "Hoertel", "first-page": "5882", "journal-title": "J Clin Med", "key": "10.1016/j.eclinm.2024.103036_bib8", "volume": "11", "year": "2022" }, { "DOI": "10.1038/s41398-022-01804-5", "article-title": "Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study", "author": "Hoertel", "doi-asserted-by": "crossref", "first-page": "90", "journal-title": "Transl Psychiatry", "key": "10.1016/j.eclinm.2024.103036_bib9", "volume": "12", "year": "2022" }, { "DOI": "10.1192/bjo.2021.1053", "article-title": "Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort", "author": "Clelland", "doi-asserted-by": "crossref", "first-page": "e6", "journal-title": "BJPsych Open", "key": "10.1016/j.eclinm.2024.103036_bib10", "volume": "8", "year": "2022" }, { "DOI": "10.1001/jama.2020.22760", "article-title": "Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial", "author": "Lenze", "doi-asserted-by": "crossref", "first-page": "2292", "journal-title": "JAMA", "key": "10.1016/j.eclinm.2024.103036_bib11", "volume": "324", "year": "2020" }, { "DOI": "10.1016/S2214-109X(21)00448-4", "article-title": "Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial", "author": "Reis", "doi-asserted-by": "crossref", "first-page": "e42", "journal-title": "Lancet Glob Health", "key": "10.1016/j.eclinm.2024.103036_bib12", "volume": "1", "year": "2022" }, { "DOI": "10.7326/M22-3305", "article-title": "Oral fluvoxamine with inhaled budesonide for treatment of early-onset COVID-19: a randomized platform trial", "author": "Reis", "doi-asserted-by": "crossref", "first-page": "667", "journal-title": "Ann Intern Med", "key": "10.1016/j.eclinm.2024.103036_bib13", "volume": "176", "year": "2023" }, { "DOI": "10.1093/ofid/ofad419", "article-title": "The STOP COVID 2 study: fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully remote randomized controlled trial", "author": "Reiersen", "doi-asserted-by": "crossref", "journal-title": "Open Forum Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib14", "volume": "10", "year": "2023" }, { "DOI": "10.1001/jama.2023.23363", "article-title": "Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19: the ACTIV-6 randomized clinical trial", "author": "Stewart", "doi-asserted-by": "crossref", "first-page": "2354", "journal-title": "JAMA", "key": "10.1016/j.eclinm.2024.103036_bib15", "volume": "24", "year": "2023" }, { "DOI": "10.1056/NEJMoa2201662", "article-title": "Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19", "author": "Bramante", "doi-asserted-by": "crossref", "first-page": "599", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2024.103036_bib16", "volume": "387", "year": "2022" }, { "DOI": "10.1001/jama.2022.24100", "article-title": "Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial", "author": "McCarthy", "doi-asserted-by": "crossref", "first-page": "296", "journal-title": "JAMA", "key": "10.1016/j.eclinm.2024.103036_bib17", "volume": "329", "year": "2023" }, { "DOI": "10.1016/j.ijid.2023.06.018", "article-title": "Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: open-label randomized controlled trial (EFFaCo study)", "author": "Siripongboonsitti", "doi-asserted-by": "crossref", "first-page": "211", "journal-title": "Int J Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib18", "volume": "134", "year": "2023" }, { "DOI": "10.1038/s41380-021-01309-5", "article-title": "The acid sphingomyelinase/ceramide system in COVID-19", "author": "Kornhuber", "doi-asserted-by": "crossref", "first-page": "307", "journal-title": "Mol Psychiatry", "key": "10.1016/j.eclinm.2024.103036_bib19", "volume": "27", "year": "2022" }, { "DOI": "10.1002/cbf.3789", "article-title": "Acid sphingomyelinase (ASM) and COVID-19: a review of the potential use of ASM inhibitors against SARS-CoV-2", "author": "Pauletto", "doi-asserted-by": "crossref", "first-page": "284", "journal-title": "Cell Biochem Funct", "key": "10.1016/j.eclinm.2024.103036_bib20", "volume": "41", "year": "2023" }, { "DOI": "10.3389/fphar.2021.755600", "article-title": "Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine shows antiviral activity against the novel variants in vitro", "author": "Fred", "doi-asserted-by": "crossref", "journal-title": "Front Pharmacol", "key": "10.1016/j.eclinm.2024.103036_bib21", "volume": "12", "year": "2022" }, { "key": "10.1016/j.eclinm.2024.103036_bib22", "series-title": "WHO Model List of Essential Medicines - 23rd List", "year": "2023" }, { "DOI": "10.1038/s41598-021-85049-0", "article-title": "The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue", "author": "Zimniak", "doi-asserted-by": "crossref", "first-page": "5890", "journal-title": "Sci Rep", "key": "10.1016/j.eclinm.2024.103036_bib23", "volume": "11", "year": "2021" }, { "DOI": "10.12688/f1000research.53275.1", "article-title": "Fluoxetine pharmacokinetics and tissue distribution suggest a possible role in reducing SARS-CoV-2 titers", "author": "Eugene", "doi-asserted-by": "crossref", "first-page": "477", "journal-title": "F1000 Research", "key": "10.1016/j.eclinm.2024.103036_bib24", "volume": "10", "year": "2021" }, { "DOI": "10.1016/S0140-6736(22)02597-1", "article-title": "Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial", "author": "Butler", "doi-asserted-by": "crossref", "first-page": "281", "journal-title": "Lancet", "key": "10.1016/j.eclinm.2024.103036_bib25", "volume": "401", "year": "2023" }, { "DOI": "10.1093/infdis/jiae052", "article-title": "Surrogate endpoints in pandemic preparedness", "author": "de Grooth", "doi-asserted-by": "crossref", "first-page": "1244", "journal-title": "J Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib26", "volume": "229", "year": "2024" }, { "DOI": "10.1016/S2666-5247(23)00398-1", "article-title": "Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis", "author": "Elias", "doi-asserted-by": "crossref", "first-page": "e459", "journal-title": "Lancet Microbe", "key": "10.1016/j.eclinm.2024.103036_bib27", "volume": "5", "year": "2024" }, { "DOI": "10.1093/jac/dkae045", "article-title": "The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis", "author": "Singh", "doi-asserted-by": "crossref", "first-page": "935", "journal-title": "J Antimicrob Chemother", "key": "10.1016/j.eclinm.2024.103036_bib28", "volume": "79", "year": "2024" }, { "article-title": "Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19", "author": "Schilling", "journal-title": "Elife", "key": "10.1016/j.eclinm.2024.103036_bib29", "volume": "12", "year": "2023" }, { "article-title": "Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants", "author": "Jittamala", "journal-title": "medRxiv", "key": "10.1016/j.eclinm.2024.103036_bib30", "year": "2022" }, { "DOI": "10.1093/infdis/jiad275", "article-title": "Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)", "author": "Jittamala", "doi-asserted-by": "crossref", "first-page": "1318", "journal-title": "J Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib31", "volume": "228", "year": "2023" }, { "DOI": "10.1186/s12879-023-08835-3", "article-title": "Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial", "author": "Luvira", "doi-asserted-by": "crossref", "first-page": "89", "journal-title": "BMC Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib32", "volume": "24", "year": "2024" }, { "DOI": "10.1016/S1473-3099(24)00183-X", "article-title": "Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)", "author": "Wongnak", "doi-asserted-by": "crossref", "first-page": "953", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib34", "volume": "24", "year": "2024" }, { "DOI": "10.1128/aac.00192-22", "article-title": "Characterizing SARS-CoV-2 viral clearance kinetics to improve the design of antiviral pharmacometric studies", "author": "Watson", "doi-asserted-by": "crossref", "journal-title": "Antimicrob Agents Chemother", "key": "10.1016/j.eclinm.2024.103036_bib35", "volume": "66", "year": "2022" }, { "DOI": "10.1016/S1473-3099(24)00254-8", "article-title": "Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscape", "author": "Visser", "doi-asserted-by": "crossref", "first-page": "936", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.eclinm.2024.103036_bib36", "volume": "24", "year": "2024" }, { "DOI": "10.1214/20-BA1221", "article-title": "Rank-normalization, folding, and localization: an improved rhat for assessing convergence of MCMC (with discussion)", "author": "Vehtari", "doi-asserted-by": "crossref", "first-page": "667", "journal-title": "Bayesian Anal", "key": "10.1016/j.eclinm.2024.103036_bib38", "volume": "16", "year": "2021" }, { "DOI": "10.1007/s11222-016-9696-4", "article-title": "Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC", "author": "Vehtari", "doi-asserted-by": "crossref", "first-page": "1413", "journal-title": "Stat Comput", "key": "10.1016/j.eclinm.2024.103036_bib39", "volume": "27", "year": "2017" }, { "article-title": "Do the selective serotonin reuptake inhibitor antidepressants fluoxetine and fluvoxamine reduce mortality among patients with COVID-19?", "author": "Hoertel", "journal-title": "JAMA Netw Open", "key": "10.1016/j.eclinm.2024.103036_bib40", "volume": "11", "year": "2021" }, { "DOI": "10.1056/NEJMoa2118542", "article-title": "Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19", "author": "Hammond", "doi-asserted-by": "crossref", "first-page": "1397", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2024.103036_bib42", "volume": "15", "year": "2022" }, { "article-title": "CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: a systematic review", "author": "Dorji", "first-page": "508", "journal-title": "J Clin Pharm Therapeut", "key": "10.1016/j.eclinm.2024.103036_bib43", "volume": "44", "year": "2019" }, { "DOI": "10.1038/s41467-024-45641-0", "article-title": "Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients", "author": "Standing", "doi-asserted-by": "crossref", "first-page": "1652", "journal-title": "Nat Commun", "key": "10.1016/j.eclinm.2024.103036_bib44", "volume": "15", "year": "2024" } ], "reference-count": 41, "references-count": 41, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2589537024006151" } }, "score": 1, "short-title": [], "source": "Crossref", "special_numbering": "C", "subject": [], "subtitle": [], "title": "Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "80" }